EE381 Comparative Cost Effectiveness of Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.629
https://www.valueinhealthjournal.com/article/S1098-3015(22)00830-0/fulltext
Title :
EE381 Comparative Cost Effectiveness of Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00830-0&doi=10.1016/j.jval.2022.04.629
First page :
Section Title :
Open access? :
No
Section Order :
10563